CN103932408B - A kind of external used medicine vest treating the syndrome of dyspnea and process for preparing medicine - Google Patents
A kind of external used medicine vest treating the syndrome of dyspnea and process for preparing medicine Download PDFInfo
- Publication number
- CN103932408B CN103932408B CN201410163813.2A CN201410163813A CN103932408B CN 103932408 B CN103932408 B CN 103932408B CN 201410163813 A CN201410163813 A CN 201410163813A CN 103932408 B CN103932408 B CN 103932408B
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- vest
- semen
- dyspnea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of external used medicine vest treating the syndrome of dyspnea and process for preparing medicine, this vest includes being respectively provided with in the middle of anter and rear panel, anter and rear panel medicated bag, the principal agent core of filling about 100g medicine, loads the auxiliary medicine core of medicine respectively in principal agent core both sides;Wherein, described principal agent core composition has: Semen Lepidii (Semen Descurainiae), Semen Sinapis Albae, Fructus Perillae, Semen Raphani, Pheretima, Semen Armeniacae Amarum, Herba Asari, Radix Kansui, Rhizoma Zingiberis, Fructus Trichosanthis, Radix Salviae Miltiorrhizae, Radix Platycodonis, Bulbus Allii Macrostemonis, Radix Achyranthis Bidentatae, adjuvant has natural resin, far infrared ceramic powder and azone.The vest of the present invention is to regulate Patients with Chuan Syndrome Characterized by Dyspnea and each internal organs comprehensively, makes each respiratory apparatus of human body tend to normal process by QI invigorating eliminating pathogen from the lung for relieving asthma, particularly becomes apparent from lung, spleen, renal function improvement.
Description
Technical field
The present invention relates to pharmaceutical formulating art, particularly relate to a kind of external used medicine vest treating the syndrome of dyspnea.
Background technology
The syndrome of dyspnea refers to due to diseases caused by exogenous pathogenic factor or internal injury, cause impairment of dispersing and descending function of the lung, abnormal rising of lung-QI or gas without being led, kidney
Mistake is taken the photograph and is received, so that dyspnea, the most then opening mouth and lifting shoulder due to dyspnea, flaring of nares, it is impossible to put down and crouch as Clinical symptoms
A kind of disease.The lighter is showed only as dyspnea, it is impossible to flat sleeping;Severe one is slightly dynamic then pants endlessly,
The most then opening mouth and lifting shoulder due to dyspnea, flaring of nares;Severe patient, dyspnea with rapid and short breath persistently do not understands, dysphoria, cyanosis of the face and lips,
Cold extremities, pearly sweating, floating-large pulse without root, the most then send out as collapse syndrome caused by dyspnea.One is that the cost for the treatment of time length is many,
Two is recurrent exerbation, susceptible disease severe symptoms autumn and winter.The reason that the syndrome of dyspnea occurs, with being invaded by exogenous pathogen, wound
It is common that, labor uncomfortable in diet, feelings will is intended to prolonged illness.Its major lesions is at lung and kidney;Dominant mechanism is
Because of diseases caused by exogenous pathogenic factor, internal injury, cause impairment of dispersing and descending function of the lung, abnormal rising of lung-QI;Gas is without being led, and kidney loses to take the photograph and receives.
The syndrome of dyspnea it is critical to " early controlling ", and the syndrome of dyspnea is the important pathogenic factor of collapse syndrome caused by dyspnea.Patients with Chuan Syndrome Characterized by Dyspnea is generally deposited
Every day will take medicine, every day will defeated 1-2 liquid, long-term hospitalization, and effect is undesirable,
Can not get radical cure, the most fundamentally do not treated.
In view of drawbacks described above, creator of the present invention obtains this finally through research for a long time and practice
Creation.
Summary of the invention
It is an object of the invention to provide a kind of external used medicine vest treating the syndrome of dyspnea and medicine preparation side
Method, in order to overcome above-mentioned technological deficiency.
For achieving the above object, the present invention provides a kind of external used medicine vest treating the syndrome of dyspnea, this vest
Including being respectively provided with medicated bag in the middle of anter and rear panel, anter and rear panel, the master of filling about 100g medicine
Medicated core, loads the auxiliary medicine core of medicine respectively in principal agent core both sides;
Wherein, described principal agent core composition have: Semen Lepidii (Semen Descurainiae), Semen Sinapis Albae, Fructus Perillae, Semen Raphani, Pheretima,
Semen Armeniacae Amarum, Herba Asari, Radix Kansui, Rhizoma Zingiberis, Fructus Trichosanthis, Radix Salviae Miltiorrhizae, Radix Platycodonis, Bulbus Allii Macrostemonis, Radix Achyranthis Bidentatae, adjuvant has sky
So resin, far infrared ceramic powder and azone.
Further, in above-mentioned principal agent core, the weight proportion of each raw material is: Semen Lepidii (Semen Descurainiae) 50-150 part, Fructus Perillae
50-150 part, Semen Sinapis Albae 50-150 part, Pheretima 100-200 part, Semen Raphani 60-180 part, Herba Asari
10-90 part, Radix Kansui 10-90 part, Rhizoma Zingiberis 30-90 part, Fructus Trichosanthis 30-90 part, Radix Salviae Miltiorrhizae 30-90 part,
Radix Platycodonis 30-90 part, Bulbus Allii Macrostemonis 30-90 part, Radix Achyranthis Bidentatae 30-90 part;The weight proportion of adjuvant is: tree
5000 parts of fat, ceramics 600 parts, azone 50 parts.
Further, the centre of described vest is circular hole, is divided into anter and rear panel with center of circular hole for boundary;
Vest is formed by the sewing of both sides Modal material, forms the cavity varied in size, opening between two layers of cloth
Upwards.
Further, the both sides of the medicated bag of vest anter load the auxiliary medicine core of the medicine of 50-100g respectively,
The both sides of the medicated bag of vest rear panel load the auxiliary medicine core of the medicine of 50-100g respectively.
Further, described medicine auxiliary medicine core composition have: Herba Lycopi, Radix Notoginseng powder, Cortex Mori, Radix Scutellariae,
Bulbus Fritillariae Cirrhosae, Rhizoma Belamcandae, Rhizoma Pinelliae Preparata, Pericarpium Citri Reticulatae, Poria, Radix Asteris, Flos Inulae, Lignum Aquilariae Resinatum, the Radix Aucklandiae, Cortex Magnoliae Officinalis,
Fructus Aurantii, Haematitum, Radix Pseudostellariae, the Radix Astragali, Radix Aconiti Lateralis Preparata, Cortex Cinnamomi, Placenta Hominis, Radix Rehmanniae Preparata, Gecko, winter worm
Summer grass, Fructus Schisandrae Chinensis, Os Draconis, Concha Ostreae.
Further, the weight proportion of the above-mentioned each raw material of auxiliary medicine core is: Herba Lycopi's 30-90 part, Radix Notoginseng powder
30-90 part, Cortex Mori 90-150 part, Radix Scutellariae 60-100 part, Bulbus Fritillariae Cirrhosae 50-90 part, Rhizoma Belamcandae 30-90
Part, Rhizoma Pinelliae Preparata 30-90 part, Pericarpium Citri Reticulatae 30-90 part, Poria 60-90 part, Radix Asteris 60-90 part, rotation
Flos Inulae 60-90 part, Lignum Aquilariae Resinatum 30-90 part, Radix Aucklandiae 30-90 part, Cortex Magnoliae Officinalis 30-90 part, Fructus Aurantii 30-90
Part, Haematitum 30-90 part, Radix Pseudostellariae 30-90 part, Radix Astragali 30-90 part, Radix Aconiti Lateralis Preparata 30-90 part,
Cortex Cinnamomi 60-90 part, Placenta Hominis 30-90 part, Radix Rehmanniae Preparata 30-90 part, Gecko 30-90 part, worm summer in winter
Grass 30-90 part, Fructus Schisandrae Chinensis 30-90 part, Os Draconis 30-90 part, Concha Ostreae 30-90 part.
The present invention also provides for the preparation method of a kind of external used medicine treating the syndrome of dyspnea, the configuration of this medicine
Process is:
Step a, is ground into powder after principal agent core and auxiliary medicine core being mixed respectively;
Step b, puts into stainless-steel pan by natural resin, is heated up to 60 to 80 degree, treats that it softens,
It is incubated 10 minutes, then is warming up to about 100 degree, be stirred continuously, make resin become wash, and
It is stirred continuously and is completely dissolved;
Step c, after being sieved by far infrared ceramic powder, is gradually added in pot, is stirred continuously, treat substrate
After being sufficiently mixed, add uniform medicated powder, stir;
Step d, is eventually adding penetrant azone, carry out after stirring completely spread out cream ovalisation or
Triangle, can be processed into principal agent core each heavy 200 grams, and auxiliary medicine core is each heavy 50-100 gram;
Step e, the pack of ready-made plaster seals,.
Further, the ratio of substrate during configuration: resin 500 grams, ceramics 60 grams, azone 5
Milliliter, Chinese medicine powder 200 grams.
Further, described principal agent core composition have: Semen Lepidii (Semen Descurainiae), Semen Sinapis Albae, Fructus Perillae, Semen Raphani, Pheretima,
Semen Armeniacae Amarum, Herba Asari, Radix Kansui, Rhizoma Zingiberis, Fructus Trichosanthis, Radix Salviae Miltiorrhizae, Radix Platycodonis, Bulbus Allii Macrostemonis, Radix Achyranthis Bidentatae, adjuvant has sky
So resin, far infrared ceramic powder and azone.
Further, auxiliary medicine core composition has: Herba Lycopi, Radix Notoginseng powder, Cortex Mori, Radix Scutellariae, Bulbus Fritillariae Cirrhosae, penetrate
Dry, Rhizoma Pinelliae Preparata, Pericarpium Citri Reticulatae, Poria, Radix Asteris, Flos Inulae, Lignum Aquilariae Resinatum, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Fructus Aurantii, generation
Haematitum, Radix Pseudostellariae, the Radix Astragali, Radix Aconiti Lateralis Preparata, Cortex Cinnamomi, Placenta Hominis, Radix Rehmanniae Preparata, Gecko, Cordyceps, five
Taste, Os Draconis, Concha Ostreae.
The beneficial effects of the present invention is compared with prior art: the vest of the present invention is to suffer from the syndrome of dyspnea
Person and each internal organs regulate comprehensively, make each respiratory apparatus of human body tend to mistake normally by QI invigorating eliminating pathogen from the lung for relieving asthma
Journey, particularly becomes apparent from lung, spleen, renal function improvement.
After Patients with Chuan Syndrome Characterized by Dyspnea external self-control 2-3 course for the treatment of of Dingchuan cream vest (1 course for the treatment of is 3 months), medicine
Effective active molecule in thing enters chest and back acupuncture point, is gone directly diseased region by the permeating volatile of medicine,
During treatment the syndrome of dyspnea, based on eliminating pathogen from the lung for relieving asthma line water detumescence, progressively control the pathogenesis of the syndrome of dyspnea,
Regulation human respiratory, promotes lung, spleen, the transporting of kidney, plays coordination and Synthetic in relievining asthma
Treatment effect, the most thoroughly reverses the syndrome of dyspnea pathogenesis, makes health reach the purpose of rehabilitation.Self-control
Dingchuan cream vest is that the morbidity root from the syndrome of dyspnea is started with, and plays and relievings asthma and strengthening vital QI to eliminate pathogenic factors recovery human body respiration
The multi-efficiencies such as function normalization and overall medical treatment complication.Vest of the present invention has following six big features:
1, treating both the principal and secondary aspects of a disease.It breaks through traditional treatment limitation, and this medicine, can be while treatment the syndrome of dyspnea
The protection respiratory tract of limits, integrated regulation cardio-pulmonary function.
2, inner disease outer treat combine that treating winter disease in summer method breaks traditions for simple oral drug therapy, its energy
Adjust the imbalance of each internal organs, the excess-dyspnea caused by deficiency of both QI and YIN and dyspnea due to deficiency.
3, many medicine comprehensive improvements are broken the normal procedure tactics, and with card plus-minus, it is with multi-medicament, makes different
Medicated core, launches an attack comprehensively, improves respiratory function, regulation and control cardiopulmonary circulation, corrects equilibrium between yin and yang, solve degasification
Road high reactive state, thus QI invigorating eliminating pathogen from the lung for relieving asthma.
4, warming lung for dispelling cold, relieving cough and asthma, dissipating phlegm and resolving masses, dredging collateral of having one's ideas straightened out, has immunosuppressive action, can
Make the patient of allergic constitution, reduce antigen antibody reaction, reduce allergy outbreak probability, also alleviated
Quick symptom.
5. QI invigorating eliminating pathogen from the lung for relieving asthma when medicinal to a certain extent time, the property of medicine slowly slow release, human body smooth absorption,
Cardiopulmonary start function progressively normalization, until basic rehabilitation lasting stability.
6, thoroughly effect a radical cure.It is not required to Long-term taking medicine, after the bioactive molecule in medicine enters human body, activates
And regulate the respiratory system of disorder so that it is tend to normal;3-4 the course for the treatment of of external, body cardio-pulmonary function
Rehabilitation, breathes and returns to normally, and consolidated, depart from medicine and do not rebound, be in health status.
Accompanying drawing explanation
Fig. 1 is the Facad structure schematic diagram that the present invention treats the external used medicine vest of the syndrome of dyspnea;
Fig. 2 is the inverse layer structure schematic diagram that the present invention treats the external used medicine vest of the syndrome of dyspnea.
Detailed description of the invention
Below in conjunction with accompanying drawing, to the present invention, above-mentioned and other technical characteristic and advantage are made more detailed
Explanation.
Referring to shown in Fig. 1 and 2, it is respectively the present invention and is just treating the external used medicine vest of the syndrome of dyspnea
Face and inverse layer structure schematic diagram, the vest of the present invention is formed by the sewing of both sides Modal material, flexible,
Skin can be close to, between two layers of cloth, form the cavity varied in size, opening upwards.
The centre of described vest is circular hole, is divided into anter 1 and rear panel 2, anter 1 with center of circular hole for boundary
It is respectively provided with oval medicated bag 3 with the centre of rear panel 2, loads the principal agent core of about 100g medicine, and
Seal with silk thread;The both sides 11 of the medicated bag 3 of vest anter 1 load the medicine of 50-100g respectively
Auxiliary medicine core, the both sides 12 of the medicated bag 3 of vest rear panel 2 load the auxiliary medicine of the medicine of 50-100g respectively
Core.
According to state of an illness needs, selecting suitable auxiliary medicine core to use, principal agent core is changed once for 30 days, auxiliary medicine
Core is changed once for 15 days, within 3 months, is a course for the treatment of, evaluates curative effect after 3 courses for the treatment of.
In the present invention, medicine used includes principal agent core and auxiliary medicine core, wherein,
Described principal agent core composition have: Semen Lepidii (Semen Descurainiae), Semen Sinapis Albae, Fructus Perillae, Semen Raphani, Pheretima, Semen Armeniacae Amarum,
Herba Asari, Radix Kansui, Rhizoma Zingiberis, Fructus Trichosanthis, Radix Salviae Miltiorrhizae, Radix Platycodonis, Bulbus Allii Macrostemonis, Radix Achyranthis Bidentatae, adjuvant have natural resin,
Far infrared ceramic powder and azone;
The weight proportion of above-mentioned each raw material is: Semen Lepidii (Semen Descurainiae) 50-150 part, Fructus Perillae 50-150 part, Caulis et Folium Sinapis albee
Sub-50-150 part, Pheretima 100-200 part, Semen Raphani 60-180 part, Herba Asari 10-90 part, Radix Kansui
10-90 part, Rhizoma Zingiberis 30-90 part, Fructus Trichosanthis 30-90 part, Radix Salviae Miltiorrhizae 30-90 part, Radix Platycodonis 30-90 part,
Bulbus Allii Macrostemonis 30-90 part, Radix Achyranthis Bidentatae 30-90 part;The weight proportion of adjuvant is: resin 5000 parts, pottery
600 parts of powder, azone 50 parts.
Auxiliary medicine core composition has: Herba Lycopi, Radix Notoginseng powder, Cortex Mori, Radix Scutellariae, Bulbus Fritillariae Cirrhosae, Rhizoma Belamcandae, system half
Summer, Pericarpium Citri Reticulatae, Poria, Radix Asteris, Flos Inulae, Lignum Aquilariae Resinatum, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Fructus Aurantii, Haematitum, too
Son ginseng, the Radix Astragali, Radix Aconiti Lateralis Preparata, Cortex Cinnamomi, Placenta Hominis, Radix Rehmanniae Preparata, Gecko, Cordyceps, Fructus Schisandrae Chinensis, dragon
Bone, Concha Ostreae.
The weight proportion of above-mentioned each raw material is: Herba Lycopi's 30-90 part, Radix Notoginseng powder 30-90 part, Cortex Mori
90-150 part, Radix Scutellariae 60-100 part, Bulbus Fritillariae Cirrhosae 50-90 part, Rhizoma Belamcandae 30-90 part, Rhizoma Pinelliae Preparata 30-90
Part, Pericarpium Citri Reticulatae 30-90 part, Poria 60-90 part, Radix Asteris 60-90 part, Flos Inulae 60-90 part, heavy
Fragrant 30-90 part, Radix Aucklandiae 30-90 part, Cortex Magnoliae Officinalis 30-90 part, Fructus Aurantii 30-90 part, Haematitum 30-90
Part, Radix Pseudostellariae 30-90 part, Radix Astragali 30-90 part, Radix Aconiti Lateralis Preparata 30-90 part, Cortex Cinnamomi 60-90 part, purple
River car 30-90 part, Radix Rehmanniae Preparata 30-90 part, Gecko 30-90 part, Cordyceps 30-90 part, the five tastes
Sub-30-90 part, Os Draconis 30-90 part, Concha Ostreae 30-90 part.
The configuration process of this medicine is:
Step a, is ground into powder after principal agent core and auxiliary medicine core being mixed respectively;
Step b, puts into stainless-steel pan by natural resin, is heated up to 60 to 80 degree, treats that it softens,
It is incubated 10 minutes, then is warming up to about 100 degree, be stirred continuously, make resin become wash, and
It is stirred continuously and is completely dissolved;
Step c, after being sieved by far infrared ceramic powder, is gradually added in pot, is stirred continuously, treat substrate
After being sufficiently mixed, add uniform medicated powder, stir;
Step d, is eventually adding penetrant azone, carry out after stirring completely spread out cream ovalisation or
Triangle, can be processed into principal agent core each heavy 200 grams, and auxiliary medicine core is each heavy 50-100 gram;
Step e, the pack of ready-made plaster seals, and can apply after three days.
Wherein, the ratio of substrate: resin 500 grams, ceramics 60 grams, azone 5 milliliters, Chinese medicine powder
200 grams.
The foregoing is only presently preferred embodiments of the present invention, be merely illustrative for invention, and
Nonrestrictive.Those skilled in the art understands, in the spirit and scope that invention claim is limited
In it can be carried out many changes, amendment, even equivalence, but fall within protection scope of the present invention
In.
Claims (8)
1. the external used medicine vest treating the syndrome of dyspnea, it is characterised in that this vest include anter and after
Being respectively provided with medicated bag in the middle of sheet, anter and rear panel, the principal agent core of filling about 100g medicine, at principal agent
Core both sides load the auxiliary medicine core of medicine respectively;
Wherein, described principal agent core composition have: Semen Lepidii (Semen Descurainiae), Semen Sinapis Albae, Fructus Perillae, Semen Raphani, Pheretima,
Semen Armeniacae Amarum, Herba Asari, Radix Kansui, Rhizoma Zingiberis, Fructus Trichosanthis, Radix Salviae Miltiorrhizae, Radix Platycodonis, Bulbus Allii Macrostemonis, Radix Achyranthis Bidentatae, adjuvant has sky
So resin, far infrared ceramic powder and azone.
The external used medicine vest for the treatment of the syndrome of dyspnea the most according to claim 1, it is characterised in that on
Stating the weight proportion of each raw material in principal agent core is: Semen Lepidii (Semen Descurainiae) 50-150 part, Fructus Perillae 50-150 part, white
Semen Sinapis 50-150 part, Pheretima 100-200 part, Semen Raphani 60-180 part, Herba Asari 10-90 part, sweet
Then 10-90 part, Rhizoma Zingiberis 30-90 part, Fructus Trichosanthis 30-90 part, Radix Salviae Miltiorrhizae 30-90 part, Radix Platycodonis 30-90
Part, Bulbus Allii Macrostemonis 30-90 part, Radix Achyranthis Bidentatae 30-90 part;The weight proportion of adjuvant is: resin 5000 parts,
Ceramics 600 parts, azone 50 parts.
The external used medicine vest for the treatment of the syndrome of dyspnea the most according to claim 2, it is characterised in that institute
The centre stating vest is circular hole, is divided into anter and rear panel with center of circular hole for boundary;Vest is by both sides not generation
You form in material sewing, form the cavity varied in size, opening upwards between two layers of cloth.
The external used medicine vest for the treatment of the syndrome of dyspnea the most according to claim 2, it is characterised in that the back of the body
The both sides of the medicated bag of heart anter load the auxiliary medicine core of the medicine of 50-100g, the medicine of vest rear panel respectively
The both sides of bag load the auxiliary medicine core of the medicine of 50-100g respectively.
The external used medicine vest for the treatment of the syndrome of dyspnea the most according to claim 1 and 2, it is characterised in that
Described medicine auxiliary medicine core composition have: Herba Lycopi, Radix Notoginseng powder, Cortex Mori, Radix Scutellariae, Bulbus Fritillariae Cirrhosae, Rhizoma Belamcandae,
Rhizoma Pinelliae Preparata, Pericarpium Citri Reticulatae, Poria, Radix Asteris, Flos Inulae, Lignum Aquilariae Resinatum, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Fructus Aurantii, Haematitum,
Radix Pseudostellariae, the Radix Astragali, Radix Aconiti Lateralis Preparata, Cortex Cinnamomi, Placenta Hominis, Radix Rehmanniae Preparata, Gecko, Cordyceps, Fructus Schisandrae Chinensis,
Os Draconis, Concha Ostreae.
The external used medicine vest for the treatment of the syndrome of dyspnea the most according to claim 5, it is characterised in that on
The weight proportion stating each raw material of auxiliary medicine core is: Herba Lycopi's 30-90 part, Radix Notoginseng powder 30-90 part, Cortex Mori
90-150 part, Radix Scutellariae 60-100 part, Bulbus Fritillariae Cirrhosae 50-90 part, Rhizoma Belamcandae 30-90 part, Rhizoma Pinelliae Preparata 30-90
Part, Pericarpium Citri Reticulatae 30-90 part, Poria 60-90 part, Radix Asteris 60-90 part, Flos Inulae 60-90 part, heavy
Fragrant 30-90 part, Radix Aucklandiae 30-90 part, Cortex Magnoliae Officinalis 30-90 part, Fructus Aurantii 30-90 part, Haematitum 30-90
Part, Radix Pseudostellariae 30-90 part, Radix Astragali 30-90 part, Radix Aconiti Lateralis Preparata 30-90 part, Cortex Cinnamomi 60-90 part, purple
River car 30-90 part, Radix Rehmanniae Preparata 30-90 part, Gecko 30-90 part, Cordyceps 30-90 part, the five tastes
Sub-30-90 part, Os Draconis 30-90 part, Concha Ostreae 30-90 part.
7. the preparation method of the external used medicine treating the syndrome of dyspnea, it is characterised in that medicine used includes
Principal agent core and auxiliary medicine core, wherein,
Described principal agent core composition have: Semen Lepidii (Semen Descurainiae), Semen Sinapis Albae, Fructus Perillae, Semen Raphani, Pheretima, Semen Armeniacae Amarum,
Herba Asari, Radix Kansui, Rhizoma Zingiberis, Fructus Trichosanthis, Radix Salviae Miltiorrhizae, Radix Platycodonis, Bulbus Allii Macrostemonis, Radix Achyranthis Bidentatae, adjuvant have natural resin,
Far infrared ceramic powder and azone;
Described auxiliary medicine core composition have: Herba Lycopi, Radix Notoginseng powder, Cortex Mori, Radix Scutellariae, Bulbus Fritillariae Cirrhosae, Rhizoma Belamcandae,
Rhizoma Pinelliae Preparata, Pericarpium Citri Reticulatae, Poria, Radix Asteris, Flos Inulae, Lignum Aquilariae Resinatum, the Radix Aucklandiae, Cortex Magnoliae Officinalis, Fructus Aurantii, Haematitum,
Radix Pseudostellariae, the Radix Astragali, Radix Aconiti Lateralis Preparata, Cortex Cinnamomi, Placenta Hominis, Radix Rehmanniae Preparata, Gecko, Cordyceps, Fructus Schisandrae Chinensis,
Os Draconis, Concha Ostreae;
The configuration process of this medicine is:
Step a, is ground into powder after principal agent core and auxiliary medicine core being mixed respectively;
Step b, puts into stainless-steel pan by natural resin, is heated up to 60 to 80 degree, treats that it softens,
It is incubated 10 minutes, then is warming up to about 100 degree, be stirred continuously, make resin become wash, and
It is stirred continuously and is completely dissolved;
Step c, after being sieved by far infrared ceramic powder, is gradually added in pot, is stirred continuously, treat substrate
After being sufficiently mixed, add uniform medicated powder, stir;
Step d, is eventually adding penetrant azone, carry out after stirring completely spread out cream ovalisation or
Triangle, can be processed into principal agent core each heavy 200 grams, and auxiliary medicine core is each heavy 50-100 gram;
Step e, the pack of ready-made plaster seals,.
The preparation method of the external used medicine for the treatment of the syndrome of dyspnea the most according to claim 7, its feature exists
In, wherein, the ratio of substrate during configuration: resin 500 grams, ceramics 60 grams, azone 5
Milliliter, Chinese medicine powder 200 grams.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410163813.2A CN103932408B (en) | 2014-04-18 | 2014-04-18 | A kind of external used medicine vest treating the syndrome of dyspnea and process for preparing medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410163813.2A CN103932408B (en) | 2014-04-18 | 2014-04-18 | A kind of external used medicine vest treating the syndrome of dyspnea and process for preparing medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103932408A CN103932408A (en) | 2014-07-23 |
CN103932408B true CN103932408B (en) | 2016-08-24 |
Family
ID=51180494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410163813.2A Expired - Fee Related CN103932408B (en) | 2014-04-18 | 2014-04-18 | A kind of external used medicine vest treating the syndrome of dyspnea and process for preparing medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103932408B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107281640A (en) * | 2017-07-21 | 2017-10-24 | 龙丹 | A kind of wound analgesic quick recovery drainage with medicated thread therapeutic equipment |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2149784Y (en) * | 1992-12-15 | 1993-12-22 | 杨化乾 | Health-care vest |
CN1100960A (en) * | 1993-10-01 | 1995-04-05 | 樊自清 | Combined health-care bag and its health belt and health clothing |
CN2441497Y (en) * | 2000-09-05 | 2001-08-08 | 王芝意 | Health vest |
CN1733014A (en) * | 2005-08-27 | 2006-02-15 | 孙恩义 | Externally applied plaster for strengthening healthy energy to stop cough and relieve asthma |
CN103239426A (en) * | 2012-02-01 | 2013-08-14 | 上海慈济药业有限公司 | Preparation method of far-infrared gel composition and preparation method of gel paste |
-
2014
- 2014-04-18 CN CN201410163813.2A patent/CN103932408B/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2149784Y (en) * | 1992-12-15 | 1993-12-22 | 杨化乾 | Health-care vest |
CN1100960A (en) * | 1993-10-01 | 1995-04-05 | 樊自清 | Combined health-care bag and its health belt and health clothing |
CN2441497Y (en) * | 2000-09-05 | 2001-08-08 | 王芝意 | Health vest |
CN1733014A (en) * | 2005-08-27 | 2006-02-15 | 孙恩义 | Externally applied plaster for strengthening healthy energy to stop cough and relieve asthma |
CN103239426A (en) * | 2012-02-01 | 2013-08-14 | 上海慈济药业有限公司 | Preparation method of far-infrared gel composition and preparation method of gel paste |
Also Published As
Publication number | Publication date |
---|---|
CN103932408A (en) | 2014-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526674A (en) | Medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven | |
CN103550717B (en) | A kind of Chinese medicine for the treatment of pneumonia | |
CN105582428A (en) | Transdermal patch for acupoint sticking therapy and preparation method thereof | |
CN103932408B (en) | A kind of external used medicine vest treating the syndrome of dyspnea and process for preparing medicine | |
CN102512540A (en) | Chinese medicine composition for treating asthma | |
CN106606719A (en) | Traditional Chinese medicine used for treating chronic cough | |
CN104288477A (en) | Traditional Chinese medicine preparation curing infantile asthma | |
CN102727738A (en) | Traditional Chinese medicine composition used for treating chronic obstructive pulmonary disease, and preparation method thereof | |
CN106344854A (en) | Blood-invigorating and tendon-relaxing foot bath powder and preparation method thereof | |
CN102580047B (en) | Chinese medicinal pills for treating kidney-deficiency asthma | |
CN105456887A (en) | Pharmaceutical for treating aplastic anemia | |
CN105477486A (en) | Pharmaceutical composition for treating pulmonary tuberculosis hemoptysis | |
CN105327196A (en) | Traditional Chinese medicine composition for treating chronic pneumonia | |
CN104707010A (en) | Traditional Chinese medicinal composition for treating pneumonia and clearing away heat and toxic materials and preparation method thereof | |
CN104147570A (en) | Traditional Chinese medicine preparation for treating children with iron deficiency anemia | |
CN104042839A (en) | Traditional Chinese medicine composition for treating tinea versicolor | |
CN101979015B (en) | Chinese medicinal preparation for treating respiratory diseases of chronic tracheitis, emphysema and pulmonary heart disease | |
CN1222364A (en) | Serial medicines for curing cancer through oral taking, dressing and medicated diet and preparation thereof | |
CN102836197A (en) | Lactation-promoting Chinese medicinal composition and preparation method thereof | |
CN106177572A (en) | A kind of Chinese medicine decoction treating aplastic anemia | |
CN105770815A (en) | Folium artemisiae argyi-containing traditional Chinese medicine composition for treating postpartum collapse and preparation method thereof | |
CN103611054B (en) | One treats leukorrhea Chinese medicine | |
CN104560509A (en) | Health-maintenance medicinal wine for enriching blood and nourishing qi | |
CN105250805A (en) | Traditional Chinese medicine for treating postpartum hypogalactia | |
CN103599497B (en) | A kind of Chinese medicine composition for the treatment of hepatitis B |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160824 Termination date: 20180418 |